BENZONATATE
- Product NDC
- 43063-979
- 11-digit product format
- 430630979
- Labeler code
- 43063
- Product ID
- 43063-979_dc8f41a5-696b-5e65-e053-2a95a90a51fb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BENZONATATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA040682
- Marketing category
- ANDA
- Marketing start
- 2018-05-01
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-979 | BENZONATATE CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 14 | Legacy NDC | 20241019_5537a8c2-4493-43e3-89f8-91da473cae3d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-979-01 | 43063097901 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43063-979-01) | 100 capsule | 2019-05-06 | 0000-00-00 | No | No | Current |